RXRX Recursion Pharmaceuticals
- 6.720
- -0.020-0.30%
Recursion Pharmaceuticals News
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher
Recursion Pharmaceuticals | 8-K: Current report
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dar Zavain
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Li Dean Y
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Taylor Ben R
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Taylor Ben R
Recursion Pharmaceuticals | 424B7: Prospectus
Recursion Pharmaceuticals | 8-K: Current report
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 8-K: Current report
Recursion Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Taylor Ben R
Recursion Pharmaceuticals | 8-K/A: Current report (Amendment)
No Data
